1. Home
  2. NICE vs BLLN Comparison

NICE vs BLLN Comparison

Compare NICE & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NICE Ltd

NICE

NICE Ltd

HOLD

Current Price

$90.25

Market Cap

5.6B

Sector

Technology

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$124.40

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NICE
BLLN
Founded
1986
2016
Country
Israel
United States
Employees
9626
713
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
6.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NICE
BLLN
Price
$90.25
$124.40
Analyst Decision
Buy
Buy
Analyst Count
13
7
Target Price
$153.46
$126.71
AVG Volume (30 Days)
475.9K
630.2K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.14
$46.29
Revenue Next Year
$9.62
$30.14
P/E Ratio
$11.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$83.10
$61.96
52 Week High
$175.00
$138.70

Technical Indicators

Market Signals
Indicator
NICE
BLLN
Relative Strength Index (RSI) 43.21 57.45
Support Level $86.40 $79.07
Resistance Level $116.83 $138.70
Average True Range (ATR) 3.55 7.26
MACD -1.31 -0.77
Stochastic Oscillator 24.43 64.34

Price Performance

Historical Comparison
NICE
BLLN

About NICE NICE Ltd

Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: